MAPT and Alzheimer disease: Finally, the results indicated that in total participants and AD patients rs3747742 was associated with the level of CSF T-tau, but not with CSF Aβ1-42 level, P-tau level, neuroimaging biomarkers and cognitive function (Table 2 and Supplementary Table 1).